Site updated at Wednesday, 22 June 2016

Living with Dementia

Amyloid Targeting Treatment

Beta secretase inhibitors to treat Alzheimer’s disease

With each new amyloid-targeting treatment for Alzheimer’s disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.

Beta secretase 1… Beta secretase inhibitors to treat Alzheimer’s disease   

Living With Dementia

neurodegenerative conditions1 - apoe43 - dementia-related diseases1 - alzheimer's-related plaque1 - brain imaging1 - sleep tied to alzheimer's1 - startle myoclonus1 - dopamine-deficient worms1 - postoperative cognitive dysfunction1 - alzheimer's plaques1 - dsm iv3 - alzheimer’s vaccine1 - risk factors for dementia1 - harvard medical school1 - the gerontological society of america1 - substantia nigra7 - gradual degeneration1 - slowness of movement1 - cognition function1 - anoea1 - alzheimer's signs1 - cjd2 - foolishness1 - caffeine2 - korsakoff's syndrome10 - als1 - reconceptualization1 - slowed movement1 - trouble sleeping1 - pick’s disease1 -